On December 11, 2020, the Food and Drug Administration issued an Emergency Use Authorization for the Pfizer-BioNTech COVID-19 vaccine. The following day, the Advisory Committee on Immunization Practices (ACIP) of the Centers for Disease Control and Prevention voted to recommend the use of the Pfizer-BioNTech COVID-19 vaccine in persons aged 16 years or older for the prevention of COVID-19.
In accordance with interim final regulations issued in October1 by the Departments of Labor, Health and Human Services, and Treasury, non-grandfathered group health plans must cover qualifying COVID-19 preventive services, including any vaccine and its administration, without cost sharing, within 15 business days of a recommendation from the United States Preventive Services Task Force or the ACIP.
The ACIP’s recommendation started the 15-business-day period, meaning that non-grandfathered group health plans must begin to cover the Pfizer-BioNTech COVID-19 vaccine with no cost sharing by January 5, 2021.
Footnote
1 See “Regulations on COVID-19 vaccine and testing requirements issued,” Insider, November 2020.
Download
| Title | File Type | File Size |
|---|---|---|
| Insider December 2020 | .2 MB |
Authors
